News

The trial evaluated nesvategrast (OTT166 5%) eye drops in patients with diabetic retinopathy.

The reverse stock split is “part of the Company’s plan to regain compliance with the minimum bid price requirement for continued listing on The Nasdaq Capital Market."

Alexander Movshovich, MD, PhD, a specialist in keratopigmentation, sat down to talk about the controversy surrounding the procedure after it went viral on social media.

Patients who underwent LASIK had undergone phacoemulsification 7 years earlier compared to a matched control group, according to the study authors.

Advances in virtual reality and AI are helping those with AMD and low vision.

Even small changes can have a large impact, saving time for physicians.

Research indicates smoking increases risk of AMD, cataracts and glaucoma

Study demonstrates that patients achieved long-term visual acuity gains following CureSight treatment.

OCU410 is a modifier gene therapy candidate being developed for geographic atrophy, an advanced stage of dry age related macular degeneration.

The transient receptor potential melastatin 8 (TRPM8) are cold-sensitive thermoreceptors that play central role in tear film homeostasis

The Clareon platform will be available in India in 2 Presbyopia correcting IOL technologies: the Clareon PanOptix and Clareon Vivity.

The collaboration combines Clario's transformative technology with Cleveland Clinic's market-leading imaging expertise and AI-enabled analysis to help bring new therapies to patients, faster.

Ferrone’s role will be effective as of March 18, 2024.

Ophthalmologists can educate their patients about the importance of using certified solar viewing glasses or other safe viewing methods.

Vermont is the latest state to consider legislation expanding the scope of practice for optometrists. Earlier this year, South Dakota became the 12th state to expand the scope of practice for optometrists.

The organization aims to educate viewers of dangers and safety precautions ahead of the eclipses.

LL-BMT1 is a novel, preservative-free, weekly drug-eluting contact lens created by the company’s proprietary 3D printing technology.

Cyclosporine superior to vehicle, improves corneal staining in dry eye disease

Delivered in a water-free solution, Vevye’s new formulation offers a high concentration of cyclosporine that works rapidly, has no preservatives, and rarely causes irritation

Investigators emphasized that the data does not indicate a causal relationship between eye disorder and systemic diseases.

In the study, published in Nature Biotechnology, researchers used their new system to correct disease-causing mutations in the eyes of two mouse models of genetic blindness, partially restoring their vision.

Their machine-learning multistage system predicts the expected disease progression of patients and their VA with age-related macular degeneration (AMD), diabetic macular edema (DME), and retinal vein occlusion (RVO).

Kiora also stated a Phase 2 trial of KIO-104 is expected to begin later this year

The study showed that a 12-day treatment of KIO-101 topically at multiple doses was well tolerated in healthy volunteers and patients with inflammation of the eye.

Results show Eylea HD extended dosing regimens were non-inferior to aflibercept 2 mg injection (Eylea) for both the treatment of wet age-related macular degeneration (wAMD) and diabetic macular edema (DME).

Investigators emphasised that the data does not indicate a causal relationship between the eye disorder and systemic diseases

The retina specialist shares advice for the clinician-scientists of a digital-centric future